Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.46 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.46 |
| ▸ | MAPT | P10636 | 2/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | RXRA | P19793 | 5/20 | 0.44 |
| ▸ | GRIN1 | Q05586 | 5/20 | 0.44 |
| ▸ | GRIN2B | Q13224 | 5/20 | 0.44 |
| ▸ | NPC1 | O15118 | 1/20 | 0.44 |
| ▸ | RAB9A | P51151 | 1/20 | 0.44 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.44 |
| ▸ | KAT6A | Q92794 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.43 |
| ▸ | MEN1 | O00255 | 2/20 | 0.43 |
| ▸ | HPGD | P15428 | 2/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | ALPG | P10696 | 1/20 | 0.43 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22632940 | 0.84 | KMT2A (0.47) | NPSR1KDM4ERXRAGRIN1GRIN2B | |
| SCHEMBL3422378 | 0.84 | RXRA (0.48) | NPSR1MAPTRXRAGRIN1GRIN2B | |
| SCHEMBL9134471 | 0.84 | NOTUM (0.47) | L3MBTL1NPSR1MAPTKDM4EMAPK1 | |
| SCHEMBL29431786 | 0.84 | EPHX2 (0.49) | L3MBTL1NPSR1MAPTKDM4EMAPK1 | |
| SCHEMBL26031073 | 0.84 | RXRA (0.48) | NPSR1MAPTRXRAGRIN1GRIN2B | |
| SCHEMBL23403693 | 0.84 | GAA (0.62) | NPSR1MAPTRXRAGRIN1GRIN2B | |
| SCHEMBL3143610 | 0.84 | NPC1 (0.50) | L3MBTL1NPSR1MAPTKDM4EMAPK1 | |
| SCHEMBL22725123 | 0.84 | EPHX2 (0.49) | L3MBTL1NPSR1MAPTKDM4EMAPK1 | |
| SCHEMBL14330837 | 0.82 | ALDH1A1 (0.52) | KDM4EMAPK1RXRAGRIN1GRIN2B | |
| SCHEMBL255496 | 0.82 | GAA (0.59) | L3MBTL1NPSR1MAPTKDM4EMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7332233-B2 | Iridium compound and organic electroluminescent device using the same | SAMSUNG SDI CO., LTD. (KR) | 2008-02-19 | — | — | US | disclosed |
| US-7332233-B2 | Iridium compound and organic electroluminescent device using the same | SAMSUNG SDI CO., LTD. (KR) | 2008-02-19 | — | — | US | disclosed |
| US-7332233-B2 | Iridium compound and organic electroluminescent device using the same | SAMSUNG SDI CO., LTD. (KR) | 2008-02-19 | — | — | US | disclosed |
| US-20050031903-A1 | Iridium compound and organic electroluminescent device using the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2005-02-10 | — | — | US | disclosed |
| CN-1154637-C | Method for producing substituted pyrazoles | �����ɷ� | 2004-06-23 | — | — | CN | disclosed |
| EP-1021416-B1 | METHOD FOR PRODUCING SUBSTITUTED PYRAZOLES | BASF AG (DE) | 2004-05-19 | — | — | EP | disclosed |
| US-6229022-B1 | REACTING CARBONYL COMPOUNDS WITH HYDRAZINE, ITS HYDRATE OR SALTS IN THE PRESENCE OF SULFURIC ACID AND IODINE OR AN IODINE LIBERATING COMPOUND | BASF AKTIENGESELLSCHAFT (DE) | 2001-05-08 | — | — | US | disclosed |
| EP-1021416-A1 | METHOD FOR PRODUCING SUBSTITUTED PYRAZOLES | BASF AKTIENGESELLSCHAFT (DE) | 2000-07-26 | — | — | EP | disclosed |
| CN-1261351-A | Process for preparing substituted pyrazoles | BASF AG (DE) | 2000-07-26 | — | — | CN | disclosed |
| WO-1998058914-A1 | METHOD FOR PRODUCING SUBSTITUTED PYRAZOLES | BASF AKTIENGESELLSCHAFT (DE) | 1998-12-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050031903-A1 | Iridium compound and organic electroluminescent device using the same | IK, ALPL, PPIP5K2 | L3MBTL1 2773/4885NPSR1 4669/4885MAPT 261/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.